Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Home
/
Trials
/
NCT00111995
NCT00111995
View on ClinicalTrials.gov
Evaluating Aranesp® for the Treatment of Anemia in African-American Subjects With Chronic Renal Failure (CRF) Receiving Hemodialysis
PHASE4
Completed
INTERVENTIONAL
Enrollment
400
Participants
Timeline
Start Date
May 31, 2002
Conditions
Chronic Renal Failure
Anemia
Interventions
DRUG
Aranesp®
Sponsors
Lead Sponsor
Amgen
All Listed Sponsors
lead
Amgen
INDUSTRY
NCT00111995 - Evaluating Aranesp® for the Treatment of Anemia in African-American Subjects With Chronic Renal Failure (CRF) Receiving Hemodialysis | Biotech Hunter | Biotech Hunter